0001104659-20-012712.txt : 20200207
0001104659-20-012712.hdr.sgml : 20200207
20200207200859
ACCESSION NUMBER: 0001104659-20-012712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200205
FILED AS OF DATE: 20200207
DATE AS OF CHANGE: 20200207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shandell Jason B.
CENTRAL INDEX KEY: 0001611148
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 20589014
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
a4.xml
4
X0306
4
2020-02-05
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001611148
Shandell Jason B.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
0
0
President and General Counsel
Common Stock
2020-02-05
4
M
0
15615
14.40
A
154513
D
Common Stock
2020-02-05
4
S
0
15615
19.568
D
138898
D
Common Stock
2020-02-06
4
M
0
21933
14.40
A
160831
D
Common Stock
2020-02-06
4
S
0
21933
19.8309
D
138898
D
Common Stock
2020-02-07
4
M
0
6853
14.40
A
145751
D
Common Stock
2020-02-07
4
S
0
6853
19.8832
D
138898
D
Employee Stock Option (right to buy)
14.40
2020-02-05
4
M
0
15615
0
D
2024-03-27
Common Stock
15615
75730
D
Employee Stock Option (right to buy)
14.40
2020-02-06
4
M
0
21933
0
D
2024-03-27
Common Stock
21933
53797
D
Employee Stock Option (right to buy)
14.40
2020-02-07
4
M
0
6853
0
D
2024-03-27
Common Stock
6853
46944
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.35 to $19.77 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $19.58 to $19.99, inclusive.
The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $19.83 to $20.00, inclusive.
Shares subject to the option are fully vested and immediately exercisable.
/s/ Eva Wen, by power of attorney
2020-02-07